ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 103 filers reported holding ALBIREO PHARMA INC in Q1 2021. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $2,468,000 | -6.0% | 70,000 | 0.0% | 0.16% | -17.0% |
| Q4 2020 | $2,626,000 | -21.3% | 70,000 | -30.0% | 0.19% | -35.2% |
| Q3 2020 | $3,337,000 | -16.0% | 100,000 | -33.3% | 0.29% | -18.1% |
| Q2 2020 | $3,974,000 | +61.8% | 150,000 | 0.0% | 0.35% | +35.1% |
| Q1 2020 | $2,456,000 | -3.4% | 150,000 | +50.0% | 0.26% | +40.1% |
| Q4 2019 | $2,542,000 | -4.4% | 100,000 | -24.8% | 0.19% | -7.9% |
| Q3 2019 | $2,660,000 | -38.0% | 133,000 | 0.0% | 0.20% | -35.6% |
| Q2 2019 | $4,288,000 | -11.3% | 133,000 | -11.3% | 0.32% | -11.8% |
| Q1 2019 | $4,832,000 | +57.6% | 150,000 | +20.0% | 0.36% | +41.1% |
| Q4 2018 | $3,066,000 | -25.6% | 125,000 | 0.0% | 0.25% | -8.0% |
| Q3 2018 | $4,120,000 | -7.2% | 125,000 | 0.0% | 0.28% | -5.8% |
| Q2 2018 | $4,438,000 | +49.2% | 125,000 | +36.9% | 0.29% | +46.7% |
| Q1 2018 | $2,974,000 | – | 91,323 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 1,704,330 | $60,504,000 | 1.59% |
| Birchview Capital, LP | 38,000 | $1,349,000 | 0.92% |
| Virtus ETF Advisers LLC | 24,688 | $876,000 | 0.77% |
| BVF INC/IL | 220,000 | $7,810,000 | 0.76% |
| SECTORAL ASSET MANAGEMENT INC | 172,803 | $6,135,000 | 0.69% |
| Chicago Capital, LLC | 134,748 | $4,784,000 | 0.39% |
| Artal Group S.A. | 500,000 | $17,750,000 | 0.38% |
| TPG Group Holdings (SBS) Advisors, Inc. | 716,381 | $25,432,000 | 0.33% |
| Eversept Partners, LP | 18,029 | $640,030 | 0.29% |
| HEARTLAND ADVISORS INC | 125,000 | $4,438,000 | 0.29% |